T.M. De Reijke

1.5k total citations
54 papers, 1.2k citations indexed

About

T.M. De Reijke is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, T.M. De Reijke has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 9 papers in Rheumatology. Recurrent topics in T.M. De Reijke's work include Prostate Cancer Treatment and Research (24 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Bladder and Urothelial Cancer Treatments (12 papers). T.M. De Reijke is often cited by papers focused on Prostate Cancer Treatment and Research (24 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Bladder and Urothelial Cancer Treatments (12 papers). T.M. De Reijke collaborates with scholars based in Netherlands, Belgium and United Kingdom. T.M. De Reijke's co-authors include Jean de la Rosette, M. A. G. Sprangers, A. L. J. Uitterhoeve, Evelien Spelten, Angela G. E. M. de Boer, Anca C. Ansink, F. J. H. van Dijk, Mark Speakman, D. H. J. Schamhart and Elizabeth C. de Boer and has published in prestigious journals such as JAMA, The Journal of Urology and British Journal of Cancer.

In The Last Decade

T.M. De Reijke

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T.M. De Reijke Netherlands 17 493 297 264 203 169 54 1.2k
P. Méria France 21 718 1.5× 171 0.6× 443 1.7× 218 1.1× 351 2.1× 138 1.6k
Dickon Hayne Australia 20 363 0.7× 391 1.3× 422 1.6× 259 1.3× 82 0.5× 105 1.1k
Mutsushi Kawakita Japan 17 451 0.9× 178 0.6× 723 2.7× 203 1.0× 172 1.0× 126 1.3k
Alexander Small United States 17 459 0.9× 137 0.5× 209 0.8× 112 0.6× 75 0.4× 74 865
Richard J. Macchia United States 24 754 1.5× 189 0.6× 680 2.6× 449 2.2× 156 0.9× 87 1.6k
Marcelo Langer Wroclawski Brazil 17 406 0.8× 144 0.5× 169 0.6× 182 0.9× 96 0.6× 62 768
Nicola Pavan Italy 21 678 1.4× 456 1.5× 462 1.8× 174 0.9× 79 0.5× 115 1.5k
Martina Maggi Italy 23 755 1.5× 159 0.5× 257 1.0× 182 0.9× 81 0.5× 96 1.5k
Vincenzo Mirone Italy 17 548 1.1× 229 0.8× 229 0.9× 139 0.7× 37 0.2× 67 931
Pierre Bigot France 17 524 1.1× 131 0.4× 401 1.5× 215 1.1× 69 0.4× 111 1.0k

Countries citing papers authored by T.M. De Reijke

Since Specialization
Citations

This map shows the geographic impact of T.M. De Reijke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.M. De Reijke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.M. De Reijke more than expected).

Fields of papers citing papers by T.M. De Reijke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.M. De Reijke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.M. De Reijke. The network helps show where T.M. De Reijke may publish in the future.

Co-authorship network of co-authors of T.M. De Reijke

This figure shows the co-authorship network connecting the top 25 collaborators of T.M. De Reijke. A scholar is included among the top collaborators of T.M. De Reijke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.M. De Reijke. T.M. De Reijke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hulscher, Marlies, Ronald B. Geskus, T.M. De Reijke, et al.. (2018). [Better antibiotic use in complicated urinary tract infections; multicentre cluster randomised trial of 2 improvement strategies].. PubMed. 160. D460–D460. 2 indexed citations
2.
Sadri‐Ardekani, Hooman, Sefika C Mizrak, Saskia K.M. van Daalen, et al.. (2010). Propagation of Human Spermatogonial Stem Cells In Vitro (vol 302, pg 2127, 2009). JAMA. 303(5). 1 indexed citations
3.
Mizrak, Sefika C, Hooman Sadri‐Ardekani, Silke F. van Daalen, et al.. (2009). Embryonic stem cell-like cells derived from adult human testis. Human Reproduction. 25(1). 158–167. 92 indexed citations
4.
Boer, Angela G. E. M. de, Evelien Spelten, A. L. J. Uitterhoeve, et al.. (2008). Work ability and return-to-work in cancer patients. British Journal of Cancer. 98(8). 1342–1347. 241 indexed citations
6.
Bolla, M., Hendrik Van Poppel, Laurence Collette, et al.. (2006). Postoperative Radiotherapy After Radical Prostatectomy: A Randomised Controlled Trial (EORTC Trial 22911). The Journal of Urology. 175(5). 1707–1708. 32 indexed citations
7.
Heijden, Antoine G. van der, Paula M.J. Moonen, Erik B. Cornel, et al.. (2006). PHASE II MARKER LESION STUDY WITH INTRAVESICAL INSTILLATION OF EOQUIN TM IN SUPERFICIAL BLADDER CANCER, TOXICITY AND MARKER RESPONSE - THE FINAL RESULTS. European Urology Supplements. 5(2). 188–188. 1 indexed citations
8.
Bolla, M., Hendrik Van Poppel, Laurence Collette, et al.. (2005). EORTC trial 22911: Immediate post-prostatectomy irradiation improves biochemical and clinical progression-free survival in patients with pathologically high risk prostate cancer. European Journal of Cancer Supplements. 3(2). 230–230. 1 indexed citations
9.
10.
Reijke, T.M. De & M. Pilar Laguna. (2003). Long‐term complications of brachytherapy in local prostate cancer. British Journal of Urology. 92(8). 869–873. 3 indexed citations
11.
Staveren, Hugo J. van, et al.. (2002). Comparison of Normal Piglet Bladder Damage after PDT with Oral or Intravesical Administration of ALA. Lasers in Medical Science. 17(4). 238–245. 5 indexed citations
12.
Bolla, M., T.M. De Reijke, Alfredo Zurlo, & Laurence Collette. (2002). Adjuvant Hormone Therapy in Locally Advanced and Localized Prostate Cancer: Three EORTC Trials. Frontiers of radiation therapy and oncology. 36. 81–86. 13 indexed citations
13.
Beerlage, Harrie P., et al.. (2000). Current Status of Minimally Invasive Treatment Options for Localized Prostate Carcinoma. European Urology. 37(1). 2–13. 51 indexed citations
14.
15.
Boer, Elizabeth C. de, et al.. (1997). Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer. Urological Research. 25(1). 31–34. 63 indexed citations
16.
Craen, Anton JM de, et al.. (1996). Does Prostate-Specific AntigenDensity Alter Decision Making onBiopsy?. European Urology. 29(1). 10–14. 2 indexed citations
17.
Ong, L.M.L., et al.. (1995). [Providing patients with an audio recording of the outpatient oncological consultation; experiences of patients and physicians].. PubMed. 139(2). 77–80. 6 indexed citations
18.
Straalen, Jan P. van, M. Bossens, T.M. De Reijke, & Gerard T. Sanders. (1994). Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy. Clinical Chemistry and Laboratory Medicine (CCLM). 32(2). 53–56. 17 indexed citations
19.
Boer, Elizabeth C. de, T.M. De Reijke, D. H. J. Schamhart, Pieter C. Vos, & K. H. Kurth. (1993). Increased urinary albumin indicating urothelial leakage following intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer. Urological Research. 21(6). 423–427. 5 indexed citations
20.
Reijke, T.M. De, et al.. (1993). The detection of prostatic carcinoma. World Journal of Urology. 11(1). 66–68. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026